| Business Name: |
Goldfarb Adam S MD |
| Contact Person: |
Adam Goldfarb |
| Address: |
100 West Magnolia Avenue, Maywood, New Jersey 07607 |
| Phone Number: |
(201) 843-8411 |
| Annual Revenue (USD): |
$1.000.000 to $2.499.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Iquit Smoking Consultation Service LLC - Maywood, NJ 07607
Rosenberg David B MD - Maywood, NJ 07607
Christiano Thomas R MD - Maywood, NJ 07607
Zaim Sina MD - Maywood, NJ 07607
Tank Lisa K MD - Maywood, NJ 07607
Sharma Shikha MD - Maywood, NJ 07607
Majersky Stephen MD - Maywood, NJ 07607
Leipsner George MD - Maywood, NJ 07607
Totaro John M MD - Maywood, NJ 07607
Academic Colon & Rectal Spec - Maywood, NJ 07607
Esposito Michael P MD - Maywood, NJ 07607
Dr's Gardy & Schepis - Maywood, NJ 07607
Secure Electronic Medical Records Group LLC - Maywood, NJ 07607
Mitnick David A MD - Maywood, NJ 07607
New Jersey Family Psych Group - Maywood, NJ 07607
David A Mitnick MD - Maywood, NJ 07607
John M Totaro Md - Maywood, NJ 07607
Jani Medical Group LLC - Maywood, NJ 07607
David Md - Maywood, NJ 07607
Sina Zaim M D LLC - Maywood, NJ 07607
|
The company Goldfarb Adam S MD provides B2C services in the form of Doctors from its single location in New Jersey.
1 to 4 employees work for Goldfarb Adam S MD, and the business now earns $1.000.000 to $2.499.999 per annum.
Goldfarb Adam S MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Goldfarb Adam S MD, please call Adam Goldfarb with the phone number (201) 843-8411 or visit its single location at 100 West Magnolia Avenue in Maywood, New Jersey 07607.
The location of the single location can also be found using the coordinates 40.90051,-74.0692.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.